Status:

COMPLETED

Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations

Lead Sponsor:

Fundación Senefro

Conditions:

ANEMIA

Eligibility:

All Genders

18+ years

Brief Summary

The purpose of this study is to evaluate the impact of the last recommendations of the European Anemia Working Group ERBP in the anemia management in the achievement of the therapeutic goal of Hb 11-1...

Eligibility Criteria

Inclusion

  • Adults patients with anemia secondary to chronic kidney disease (CKD) not on dialysis.
  • Patients starting anemia treatment (naïve) after six months of the last recommendations of the European Anemia Working Group ERBP (January 2011).
  • Patients in treatment who changed from previous ESA treatment since January 2011 (converted patients

Exclusion

  • Patients in Erythropoiesis Stimulating Agents (ESA) dose adjustment period.
  • Kidney transplant patients.

Key Trial Info

Start Date :

October 1 2011

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2012

Estimated Enrollment :

455 Patients enrolled

Trial Details

Trial ID

NCT01903148

Start Date

October 1 2011

End Date

June 1 2012

Last Update

January 1 2014

Active Locations (29)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (29 locations)

1

Hospital Puerto Real

Cadiz, Andalusia, Spain

2

Hospital de Jerez

Jerez de la Frontera, Andalusia, Spain

3

Clínico V. Victoria

Málaga, Andalusia, Spain

4

Hospital Son Llatzer

Palma de Mallorca, Balearic Islands, Spain